Camila Reyes-Ordonez
Bogota, DC, Colombia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
Molecular Tumor Board Improves Outcomes for Hispanic Patients With Advanced Solid Tumors.
Journal: JCO global oncology
Published: January 18, 2024
DICER1-associated central nervous system sarcoma: A comprehensive clinical and genomic characterization of case series of young adult patients.
Journal: Neuro-oncology practice
Published: July 17, 2023
Application of Comprehensive Genomic Profiling-Based Next-Generation Sequencing Assay to Improve Cancer Care in a Developing Country.
Journal: Cancer control : journal of the Moffitt Cancer Center
Published: May 06, 2023
Genomic Landscape of Primary Resistance to Osimertinib Among Hispanic Patients with EGFR-Mutant Non-Small Cell Lung Cancer (NSCLC): Results of an Observational Longitudinal Cohort Study.
Journal: Targeted oncology
Published: February 19, 2023
Integration of artificial intelligence and precision oncology in Latin America.
Journal: Frontiers in medical technology
Published: July 31, 2022
STK11 and KEAP1 mutations in non-small cell lung cancer patients: Descriptive analysis and prognostic value among Hispanics (STRIKE registry-CLICaP).
Journal: Lung cancer (Amsterdam, Netherlands)
Published: May 24, 2022
Bispecific Antibodies in Cancer Immunotherapy: A Novel Response to an Old Question.
Journal: Pharmaceutics
Published: April 24, 2022
Durvalumab After Chemoradiation for Unresectable Stage III Non-Small Cell Lung Cancer: Inferior Outcomes and Lack of Health Equity in Hispanic Patients Treated With PACIFIC Protocol (LA1-CLICaP).
Journal: Frontiers in oncology
Published: March 25, 2022
Mechanisms of Resistance to First-Line Osimertinib in Hispanic Patients With EGFR Mutant Non-Small Cell Lung Cancer (FRESTON-CLICaP).
Journal: Clinical lung cancer
Published: March 25, 2022
EGFR Inhibitors Plus Bevacizumab are Superior Than EGFR Inhibitors Alone as First-Line Setting in Advanced NSCLC With EGFR Mutations and BIM Deletion Polymorphisms (BIM-CLICaP).
Journal: JCO precision oncology
Published: January 07, 2022
Human papillomavirus infection and lung adenocarcinoma: special benefit is observed in patients treated with immune checkpoint inhibitors.
Journal: ESMO open
Published: December 15, 2021
High-risk human papillomavirus infection among women living with HIV in Latin America and the Caribbean: A systematic review and meta-analysis.
Journal: International journal of STD & AIDS
Published: September 07, 2021
Last Updated: 09/26/2026